4 hours Enanta Pharmaceuticals (NASDAQ:ENTA) Rating Reiterated by JMP Securities MarketBeat
JMP Securities reiterated a “market outperform” rating and set a $22.00 price objective on shares of Enanta Pharmaceuticals in a research report on Friday.
Nasdaq 100 · Pharmaceuticals · Science